Literature DB >> 18477040

Hairy cell leukaemia: a heterogeneous disease?

Graça M Dores1, Rayna K Matsuno, Dennis D Weisenburger, Philip S Rosenberg, William F Anderson.   

Abstract

The US National Cancer Institute's Surveillance, Epidemiology and End Results program was used to develop aetiological clues for hairy cell leukaemia (HCL). Descriptive techniques (age-adjusted incidence trends, age-specific incidence rates (IR), and age distributions-at-diagnosis) were supplemented with mathematical models (two-component mixture, generalized linear regression, and age-period-cohort). There were 2856 cases of HCL diagnosed during 1978-2004 (IR 0.32/100,000 person-years). IRs were nearly 4-fold greater among men than women and more than 3-fold higher for Whites than Blacks. Temporal trends were stable over time. Age-specific IRs increased rapidly until approximately 40 years then rose at a slower pace. The age-specific IR curves reflected bimodal early- and late-onset age distributions-at-diagnosis (or density plots), with some variation by gender. Among both men and women, a two-component mixture model fitted the data better than a single density or cancer population. Age-period-cohort models confirmed statistically significant age-related effects after full adjustment for temporal trends (calendar-period and birth-cohort effects). In summary, age incidence patterns (rates and bimodal densities) suggested that HCL is a heterogeneous disease, consisting of at least two underlying subgroups and/or cancer populations by age-at-onset. Distinct early- and late-onset HCL populations may reflect different age-related causal pathways, risk factor profiles, and/or stem cells of origin.

Entities:  

Mesh:

Year:  2008        PMID: 18477040      PMCID: PMC4009349          DOI: 10.1111/j.1365-2141.2008.07156.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  38 in total

1.  The natural history and clinico-pathological features of the variant form of hairy cell leukemia.

Authors:  E Matutes; A Wotherspoon; V Brito-Babapulle; D Catovsky
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

2.  Treatment of hairy cell leukemia-variant with cladribine.

Authors:  S A Tetreault; B A Robbins; A Saven
Journal:  Leuk Lymphoma       Date:  1999-10

3.  Epidemiology of hairy cell leukemia in Los Angeles County.

Authors:  L Bernstein; P Newton; R K Ross
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

4.  Epidemiology of Hodgkin's disease.

Authors:  P Cole
Journal:  JAMA       Date:  1972-12-25       Impact factor: 56.272

5.  Leukemic reticuloendotheliosis. The role of tartrate-resistant acid phosphatase in diagnosis and splenectomy in treatment.

Authors:  L T Yam; C Y Li; H E Finkel
Journal:  Arch Intern Med       Date:  1972-08

6.  Hairy cell leukemia in first cousins and review of the literature.

Authors:  M D Colovic; G M Jankovic; P H Wiernik
Journal:  Eur J Haematol       Date:  2001-09       Impact factor: 2.997

Review 7.  Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey.

Authors:  W Y Au; Y L Kwong; S K Ma; Y K Mak; K F Wong; K I Lei; M H Ng; J C Chan; S Y Lin; K K Lee; R Liang
Journal:  Hematol Oncol       Date:  2000-12       Impact factor: 5.271

8.  Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.

Authors:  W F Anderson; K C Chu; N Chatterjee; O Brawley; L A Brinton
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

9.  Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model.

Authors:  R M Pfeiffer; M H Gail; L M Brown
Journal:  J Epidemiol Biostat       Date:  2000

10.  Epidemiology of hairy cell leukemia in Iceland.

Authors:  Sigurdur Yngvi Kristinsson; Brynjar Vidarsson; Bjarni A Agnarsson; Vilhelmina Haraldsdottir; Orn Olafsson; Gudmundur M Johannesson; Gudmundur I Eyjolfsson; Johanna Bjornsdottir; Pall T Onundarson; Sigrun Reykdal
Journal:  Hematol J       Date:  2002
View more
  11 in total

1.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

2.  Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.

Authors:  Dai Chihara; Evgeny Arons; Maryalice Stetler-Stevenson; Constance M Yuan; Hao-Wei Wang; Hong Zhou; Mark Raffeld; Liqiang Xi; Seth M Steinberg; Julie Feurtado; Lacey James; Wyndham Wilson; Raul C Braylan; Katherine R Calvo; Irina Maric; Alina Dulau-Florea; Robert J Kreitman
Journal:  J Clin Oncol       Date:  2020-02-28       Impact factor: 44.544

Review 3.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

4.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

Review 5.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

6.  Autoimmune conditions and hairy cell leukemia: an exploratory case-control study.

Authors:  Lesley A Anderson; Eric A Engels
Journal:  J Hematol Oncol       Date:  2010-10-04       Impact factor: 17.388

7.  Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Alain Monnereau; Susan L Slager; Ann Maree Hughes; Alex Smith; Bengt Glimelius; Thomas M Habermann; Sonja I Berndt; Anthony Staines; Aaron D Norman; James R Cerhan; Joshua N Sampson; Lindsay M Morton; Jacqueline Clavel
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

8.  Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.

Authors:  Naval Daver; Aziz Nazha; Hagop M Kantarjian; Rodney Haltom; Farhad Ravandi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-14

9.  Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations.

Authors:  Marion Haugen; Freddie Bray; Tom Grotmol; Steinar Tretli; Odd O Aalen; Tron A Moger
Journal:  Biostatistics       Date:  2009-03-29       Impact factor: 5.899

10.  Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.

Authors:  Şeniz Öngören; Ahmet Emre Eşkazan; Selin Berk; Tuğrul Elverdi; Ayşe Salihoğlu; Muhlis Cem Ar; Zafer Başlar; Yıldız Aydın; Nükhet Tüzüner; Teoman Soysal
Journal:  Turk J Haematol       Date:  2017-12-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.